Activating Ras mutations in patients with plasma-cell disorders: a reappraisal-Reference-Cited by-同舟云学术

Activating Ras mutations in patients with plasma-cell disorders: a reappraisal

Published:2002-08-01 Issue:3 Volume:100 Page:1101-1104
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Bezieau Stéphane¹,Avet-Loiseau Hervé¹,Moisan Jean-Paul¹,Bataille Régis¹

Affiliation:

1. Correspondence: Stéphane Bezieau and Régis Bataille, Laboratoire d'Hématologie, Institut de Biologie, 9, quai Moncousu, 44093 Nantes Cedex 01, France

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/100/3/1101/1684829/h81502001092g.pdf

Reference10 articles.

1. Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation.;Kalakonda;Blood.,2001

2. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.;Bezieau;Hum Mut.,2001

3. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.;Liu;Blood.,1996

4. Ras oncogene mutation in multiple myeloma.;Neri;J Exp Med.,1989

5. Oncogenes in multiple myeloma: point mutation of N-ras.;Paquette;Oncogene.,1990

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II trial of BAY 43‐9006 (sorafenib) ( NSC ‐724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434;Cancer Medicine;2014-06-10

2. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo;British Journal of Haematology;2010-03-12

3. Novel biological therapies for the treatment of multiple myeloma;Best Practice & Research Clinical Haematology;2005-12

4. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors;Blood;2005-01-01

5. Interference with signaling pathways in malignant disease;Textbook of Malignant Haematology, Second Edition;2004-12-14